Welcome
Support Centre
04 July 2009 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The anal fistula PLUG versus the mucosal flap advancement for the treatment of perianal fistulas
ISRCTN ISRCTN97376902
ClinicalTrials.gov identifier
Public title The anal fistula PLUG versus the mucosal flap advancement for the treatment of perianal fistulas
Scientific title
Acronym PLUG
Serial number at source N/A
Study hypothesis The anal fistula plug is superior in the treatment of high transphincteric fistulas compared to the mucosal advancement flap.
Ethics approval Approval received from the Medical Ethics Committee AMC, Amsterdam on the 23rd August 2006 (ref: MEC 06/204).
Study design Multicentre, randomised, double blinded, active controlled, parallel group trial
Countries of recruitment The Netherlands
Disease/condition/study domain Perianal fistula
Participants - inclusion criteria 1.High anorectal fistula of cryptoglandular origin (transphincteric, upper 2/3 of the sphincter complex which is confined by the puborectal sling and the end of the anal canal)
2. Informed consent
Participants - exclusion criteria 1. Aged less than 18 years
2. Human Immunodeficiency Virus (HIV)-positive
3. Crohn's disease
4. Malignant cause
5. Tuberculosis
6. Hidradenitis suppurativa
7. Pilonidal sinus disease
8. No internal opening found during surgery
Anticipated start date 01/10/2006
Anticipated end date 01/10/2007
Status of trial Completed
Patient information material
Target number of participants 60
Interventions installation of the anal fistula plug versus mucosal flap.
Primary outcome measure(s) 1. Anorectal fistula closure rate
2. Continence
Secondary outcome measure(s) 1. Morbidity
2. Post-operative pain
3. Sick leave
4. Quality of life
Sources of funding Academic Medical Centre (AMC) (The Netherlands)
Trial website
Publications
Contact name Dr  J.F.M.   Slors
  Address Academic Medical Centre
Afd. Chirurgie
  City/town Amsterdam
  Zip/Postcode 1105 AZ
  Country Netherlands
  Tel +31 (0)20 566 9111
  Email j.f.slors@amc.uva.nl
Sponsor Academic Medical Centre (AMC) (The Netherlands)
  Address Department of Surgery
P.O. Box 22660
  City/town Amsterdam
  Zip/Postcode 1100 DD
  Country Netherlands
  Sponsor website: http://www.amc.uva.nl#http://www.amc.uva.nl/
Date applied 16/07/2007
Last edited 27/07/2007
Date ISRCTN assigned 16/07/2007
Submit your trial protocol Submit to Trials journal
© ISRCTN


BioMed Central